BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 28939075)

  • 1. Incidence of facial nerve sacrifice in parotidectomy for primary and metastatic malignancies.
    Swendseid B; Li S; Thuener J; Rezaee R; Lavertu P; Fowler N; Zender C
    Oral Oncol; 2017 Oct; 73():43-47. PubMed ID: 28939075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parotidectomy for Parotid Cancer.
    Cracchiolo JR; Shaha AR
    Otolaryngol Clin North Am; 2016 Apr; 49(2):415-24. PubMed ID: 26895698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial nerve function after parotidectomy.
    Bron LP; O'Brien CJ
    Arch Otolaryngol Head Neck Surg; 1997 Oct; 123(10):1091-6. PubMed ID: 9339986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parotidectomy in the treatment of aggressive cutaneous malignancies.
    Lai SY; Weinstein GS; Chalian AA; Rosenthal DI; Weber RS
    Arch Otolaryngol Head Neck Surg; 2002 May; 128(5):521-6. PubMed ID: 12003582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of the margin in parotid surgery for pleomorphic adenoma.
    Witt RL
    Laryngoscope; 2002 Dec; 112(12):2141-54. PubMed ID: 12461331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of adenoid cystic carcinoma in the parotid gland.
    Casler JD; Conley JJ
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):332-8. PubMed ID: 1314372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary and non-primary parotid malignancies: comparison of treatment modalities and outcomes.
    Morinière S; Périé S; Lacau St Guily J
    Eur Arch Otorhinolaryngol; 2007 Oct; 264(10):1231-7. PubMed ID: 17534637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep lobe parotidectomy: clinical rationale in the management of primary and metastatic cancer.
    Olsen KD; Moore EJ
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):1181-5. PubMed ID: 23832259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional outcomes after extracapsular dissection with partial facial nerve dissection for small and large parotid neoplasms.
    Auger SR; Kramer DE; Hardy B; Jandali D; Stenson K; Kocak M; Al-Khudari S
    Am J Otolaryngol; 2021; 42(1):102770. PubMed ID: 33188987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporary facial nerve dysfunction after parotidectomy correlates with tumor location.
    Ikoma R; Ishitoya J; Sakuma Y; Hirama M; Shiono O; Komatsu M; Oridate N
    Auris Nasus Larynx; 2014 Oct; 41(5):479-84. PubMed ID: 24882585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial parotidectomy versus retrograde partial superficial parotidectomy in treating benign salivary gland tumor (pleomorphic adenoma).
    Emodi O; El-Naaj IA; Gordin A; Akrish S; Peled M
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2092-8. PubMed ID: 20728030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative parotidectomy for the treatment of parotid cancers.
    Lim YC; Lee SY; Kim K; Lee JS; Koo BS; Shin HA; Choi EC
    Oral Oncol; 2005 Nov; 41(10):1021-7. PubMed ID: 16129655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial nerve dysfunction after parotidectomy: the role of local factors.
    Gaillard C; Périé S; Susini B; St Guily JL
    Laryngoscope; 2005 Feb; 115(2):287-91. PubMed ID: 15689752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Facial Nerve Outcome in Primary Parotid Cancer Surgery: A Population-Based Analysis.
    Thielker J; Wahdan A; Buentzel J; Kaftan H; Boeger D; Mueller AH; Wittig A; Schultze-Mosgau S; Ernst T; Guntinas-Lichius O
    Laryngoscope; 2021 Dec; 131(12):2694-2700. PubMed ID: 34050959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total versus superficial parotidectomy for stage III melanoma.
    Wertz AP; Durham AB; Malloy KM; Johnson TM; Bradford CR; McLean SA
    Head Neck; 2017 Aug; 39(8):1665-1670. PubMed ID: 28481438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial nerve sacrifice and tumor recurrence in primary and recurrent benign parotid tumors.
    O'Dwyer PJ; Farrar WB; Finkelmeier WR; McCabe DP; James AG
    Am J Surg; 1986 Oct; 152(4):442-5. PubMed ID: 3021010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for partial parotidectomy using retrograde dissection of the marginal mandibular branch of the facial nerve for benign tumours of the parotid gland.
    Suzuki K; Iwai H; Yagi M; Fujisawa T; Kanda A; Konishi M; Kobayashi Y; Tomoda K; Yamashita T
    Br J Oral Maxillofac Surg; 2018 Oct; 56(8):727-731. PubMed ID: 30115458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Facial Nerve Monitoring With Postoperative Facial Paralysis in Parotidectomy.
    Savvas E; Hillmann S; Weiss D; Koopmann M; Rudack C; Alberty J
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):828-33. PubMed ID: 27310887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial nerve function after parotidectomy for neoplasms with deep localization.
    Marchesi M; Biffoni M; Trinchi S; Turriziani V; Campana FP
    Surg Today; 2006; 36(4):308-11. PubMed ID: 16554985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial superficial parotidectomy as the method of choice for treating pleomorphic adenomas of the parotid gland.
    Papadogeorgakis N
    Br J Oral Maxillofac Surg; 2011 Sep; 49(6):447-50. PubMed ID: 20638162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.